Using Tumor-Informed Circulating Tumor DNA (ctDNA)-Based Testing for Patients with Anal Squamous Cell Carcinoma Article Early Access

Industry Collaboration

cited authors

  • Azzi, Georges; Tavallai, Mehrad; Aushev, Vasily N.; Koyen Malashevich, Allyson; Botta, Gregory P.; Tejani, Mohamedtaki A.; Hanna, Diana; Krinshpun, Shifra; Malhotra, Meenakshi; Jurdi, Adham; Aleshin, Alexey; Kasi, Pashtoon M.

authors

Publication Date

  • December 23, 2022

webpage

published in

category

keywords

  • anal squamous cell carcinoma
  • circulating tumor DNA
  • minimal
  • molecular residual disease
  • prognostic biomarker